Aptevo Therapeutics Inc. Stock Analysis & AI Score
Aptevo Therapeutics Inc. (APVO) has an ST Score of 25.5 (D+), driven by its Growth (A+) and held back by its Momentum (F). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Aptevo Therapeutics Inc. (APVO) has an ST Score of 25.5 (D+), driven by its Growth (A+) and held back by its Momentum (F). Analysts rate it Buy.
- Strongest
- GrowthA+
- Weakest
- MomentumF
All factor grades
- GrowthA+
- ValuationC
- Financial StrengthD-
- ProfitabilityF
- MomentumF
- Piotroski1/9
Contact
APVO stock: frequently asked questions
What is APVO's ST Score?
Aptevo Therapeutics Inc. (APVO) has an ST Score of 25.5 (D+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is APVO a buy, hold, or sell?
Analysts rate APVO a Buy. Our ST Score grades it D+ (25.5/100). The ST Score is a data-driven signal, not a recommendation.
What are APVO's factor grades?
Valuation C, Profitability F, Financial Strength D-, Momentum F, Growth A+.
What is APVO's valuation grade?
Aptevo Therapeutics Inc. (APVO) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is APVO's growth grade?
Aptevo Therapeutics Inc. (APVO) earns a growth grade of A+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is APVO's profitability grade?
Aptevo Therapeutics Inc. (APVO) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is APVO's financial strength grade?
Aptevo Therapeutics Inc. (APVO) earns a financial strength grade of D-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is APVO's Piotroski score?
Aptevo Therapeutics Inc. (APVO) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.